ETFChannel.com
SLIDESHOW: The Top 25 Broker Analyst Picks of the S&P 500
By ETF Channel Staff, updated Tue, September 27, 1:40 PM
| This Slide: #1 of 25 |
#25 of the S&P 500: DexCom Inc (NASDAQ:DXCM)
DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients. 
Open the DXCM Page at ETF Channel »
|
|||||||||||||||||||||
Open the ETF Channel DXCM Page (in a new window) »
DXCM Average Broker Rec.
 
|
Strong Buy (3.79 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
 Free DXCM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Avg. Broker Rec.
|
Strong Buy (3.79 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Analysts Forecast: DXCM Price Target Based on data provided by Zacks Investment Research via Quandl.com |
|
|
